All In Biotech

Drug Trial Radar · NCT00066170

Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy

Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem (Sodium Oxybate) and Modafinil With Placebo in Treatment of Daytime Sleepiness in Narcolepsy

Last checked: Nov 19, 2026Latest source record: Dec 29, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 231 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

231

Actual

Start

Apr 2003

Primary completion

Jul 2004

Study completion Nov 2004

Sponsor

Lead sponsor
Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
Sponsor type
Industry
First posted
Aug 6, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will be conducted as a randomized, double blind, double-dummy, placebo-controlled, parallel-group trial in patients diagnosed with narcolepsy. Volunteers for this trial will be required to make 5 visits over up to 14 weeks to a participating expert physician practitioner for various sleep and narcolepsy evaluations and diaries will also be collected. Participants will take assigned medications during the course of the trial. Subjects will have a 25% probability of receiving placebo for both drugs (modafinil and Xyrem). All subject volunteers must meet criteria for narcolepsy and have evidence of daytime sleepiness. Patients will not incur any personal medical expenses due to participation in this trial. The sponsor is covering all visit costs not covered by insurance and there are some funds for patient expenses such as travel.

Conditions

  • Narcolepsy

Interventions

  • XyremDrug

    Xyrem oral solution at 6 g/day for 4 weeks and 9 g/day for another 4 weeks.

  • Xyrem PlaceboDrug

    Xyrem Placebo oral solution 12 ml per day for 4 weeks and 18 ml per day for another 4 weeks.

  • Modafinil at established doseDrug

    Modafinil oral capsules at 200 to 600 mg per day for 8 weeks.

  • Modafinil (Placebo)Drug

    Modafinil Placebo oral capsules 1 to 3 capsules per day for 8 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Daytime Sleep Latency as Measured by the Maintenance of Wakefulness Test (MWT)Time frame: Baseline to Week 8

Locations

40 sites in 4 countries. Site status is shown where the registry gives one.

  • Pulmonary Associates, PA

    Phoenix, Arizona

  • St. Jude Medical Center -- Sleep Disorders Institute

    Fullerton, California

  • Pacific Sleep Medicine Services, Inc.

    Los Angeles, California

  • Neuro-Therapeutics, Inc.

    Pasadena, California

  • Pacific Sleep Medicine Services, Inc.

    San Diego, California

  • Stanford Sleep Disorders Clinic

    Stanford, California

  • Clinical Research Group of St. Petersburg, Inc.

    St. Petersburg, Florida

  • Peoria Pulmonary Associates, Ltd

    Peoria, Illinois

  • The Center for Sleep and Wake Disorders/Midwest Neurology

    Danville, Indiana

  • Graves Gilbert Clinic

    Bowling Green, Kentucky

  • Community Research & Sleep Management Institute

    Crestview Hills, Kentucky

  • Chest Medicine Associates DBA -- Sleep Medicine Specialists

    Louisville, Kentucky

  • The Center for Sleep & Wake Disorders

    Chevy Chase, Maryland

  • Sleep Disorders Center -- Union Hospital of Cecil County

    Elkton, Maryland

  • Sleep Medicine Associates of Maryland

    Towson, Maryland

  • Henry Ford Hospital

    Detroit, Michigan

  • Washington University Sleep Center

    St Louis, Missouri

  • New Jersey Neuroscience Institute at JFK Medical Center

    Edison, New Jersey

  • Sleep Disorders Center of Rochester

    Rochester, New York

  • Strong Sleep Disorders Center

    Rochester, New York

  • Raleigh Neurology Associates

    Raleigh, North Carolina

  • ALL-TRIALS Clinical Research, LLC -- Summit Sleep Disorder

    Winston-Salem, North Carolina

  • Cincinnati Clinic & Sleep Management Institute

    Cincinnati, Ohio

  • Community Research Management Associates,Inc.

    Cincinnati, Ohio

  • CSC Research -- Grove City Sleep Diagnostic Center

    Grove City, Ohio

  • Lehigh Valley Hospital Sleep Disorders Center

    Allentown, Pennsylvania

  • Capital Region Sleep Disorder Center

    Carlisle, Pennsylvania

  • Center for Sleep Medicine

    Lafayette Hill, Pennsylvania

  • Lowcountry Lung and Critical Care, PA

    Charleston, South Carolina

  • SleepMed of South Carolina

    Columbia, South Carolina

  • SDHRF Clinical Research Center

    Sioux Falls, South Dakota

  • Sioux Valley Clinic -- Pulmonary

    Sioux Falls, South Dakota

  • Sleep Disorders Center

    Sioux Falls, South Dakota

  • Bhupesh Dihenia, MD

    Lubbock, Texas

  • SLEEP WALKER -- Sleep Disorders Center & Neurodiagnostics--Lung Diagnostics, Ltd.

    San Antonio, Texas

  • Vermont Medical Sleep Disorders Center, Inc.

    Essex Junction, Vermont

  • Hopital Pitie Salpetriere -- Federation des Pathologies du sommeil

    Paris, Cedex 13, France

  • Centre du sommeil -- Hopital Gui de Chauliac

    Montpellier, Cedex 5, France

  • Psychiatrische Universitatsklinik

    Regensburg, Germany

  • Neurologische Poliklinik -- Universitats Spital Zurich

    Zurich, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.